These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR. Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [Abstract] [Full Text] [Related]
3. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A. Adv Perit Dial; 1996 Feb; 12():261-5. PubMed ID: 8865916 [Abstract] [Full Text] [Related]
4. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide]. Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L. Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435 [Abstract] [Full Text] [Related]
5. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Denke MA, Grundy SM. Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022 [Abstract] [Full Text] [Related]
6. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H. Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706 [Abstract] [Full Text] [Related]
7. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Farnier M, Bonnefous F, Debbas N, Irvine A. Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177 [Abstract] [Full Text] [Related]
8. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR. Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811 [Abstract] [Full Text] [Related]
9. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up]. Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B. Z Kardiol; 1995 Feb 07; 84(2):130-6. PubMed ID: 7717016 [Abstract] [Full Text] [Related]
10. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia]. Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J. Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396 [Abstract] [Full Text] [Related]
11. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results. Ros E, Zambón D, Bertomeu A, Cusó E, Sanllehy C, Casals E. Arch Intern Med; 1991 Feb 25; 151(2):301-5. PubMed ID: 1992957 [Abstract] [Full Text] [Related]
12. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia]. Catalán M, López de Ocáriz A, Alvarez MP, Ariño M, Azanza JR, Honorato J. Rev Med Univ Navarra; 1992 Feb 25; 37(3):127-33. PubMed ID: 1480917 [Abstract] [Full Text] [Related]
13. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia. O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D. Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801 [Abstract] [Full Text] [Related]
14. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G. Can J Cardiol; 1993 Jun 07; 9(5):405-12. PubMed ID: 8348392 [Abstract] [Full Text] [Related]
15. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study]. Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A. Minerva Cardioangiol; 1993 Mar 07; 41(3):105-9. PubMed ID: 8510811 [Abstract] [Full Text] [Related]
16. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B. Clin Ther; 1991 Mar 07; 13(4):500-10. PubMed ID: 1934003 [Abstract] [Full Text] [Related]
17. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. Darling GM, Johns JA, McCloud PI, Davis SR. N Engl J Med; 1997 Aug 28; 337(9):595-601. PubMed ID: 9271481 [Abstract] [Full Text] [Related]
18. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Moreyra AE, Wilson AC, Koraym A. Arch Intern Med; 2005 May 23; 165(10):1161-6. PubMed ID: 15911730 [Abstract] [Full Text] [Related]
19. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug]. Mol MJ, Stuyt PM, Stalenhoef AF. Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555 [Abstract] [Full Text] [Related]
20. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR. Wien Med Wochenschr; 1995 Feb 18; 145(21):577-83. PubMed ID: 8560901 [Abstract] [Full Text] [Related] Page: [Next] [New Search]